A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country
<h3>Background</h3><p dir="ltr">Sodium glucose co-transporter 2 inhibitors (SGLT2is) are a novel class of oral antidiabetic drugs. To date, there are no pharmacoepidemiologic studies investigating the pattern of use of SGLT2is compared to other oral antidiabetic drugs in...
Saved in:
| Main Author: | Nancy Zaghloul (14147865) (author) |
|---|---|
| Other Authors: | Ahmed Awaisu (5121473) (author), Ahmed Mahfouz (737928) (author), Sumaya Alyafei (14147868) (author), Hazem Elewa (3592601) (author) |
| Published: |
2022
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating the appropriateness and the factors associated with sodium-glucose co-transporter 2 inhibitors prescribing in a Middle Eastern country: a cross-sectional study
by: Nancy Zaghloul (14147865)
Published: (2024) -
Efficacy of sodium-glucose co-transporter 2 inhibitors in patients with type II diabetes
by: Mohammed Ibn-Mas’ud Danjuma (13192169)
Published: (2019) -
A Comparative Study of Safety Outcomes of Sodium Glucose Cotransporter-2 Inhibitors and Loop Diuretics Among Diabetic Patients Using Real-world Data
by: Alaa Rahhal (14150403)
Published: (2022) -
Potential Therapeutic Effects of Sodium Glucose-linked Cotransporter 2 Inhibitors in Stroke
by: Fatima Alzahra Al Hamed (17115562)
Published: (2020) -
Understanding the Mechanism of Dysglycemia in a Fanconi-Bickel Syndrome Patient
by: Sanaa Sharari (12561952)
Published: (2022)